Catch up on your JDD reading with highlights from the August issue, Special Focus: Psoriasis.
Strober, Bagel, and Lebwohl et al present Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study READ NOW
The Static Physician’s Global Assessment of Genitalia: A Clinical Outcome Measure for the Severity of Genital Ps … Continue reading "JDD August Highlights – Special Focus: Psoriasis"
INTRODUCTION
Periocular basal cell carcinoma (BCC) is the most common eyelid malignancy concomitant with ocular morbidity and quality of life impact.1,2 Orbital invasion occurs in 2% of cases and poses challenges for management.1,3 JDD authors highlight a multidisciplinary approach to the treatment of advanced periocular BCC.
CASE
JDD authors discuss a 56-year-old male who presente … Continue reading "Treatment of Advanced Basal Cell Carcinoma With Involvement of the Left Orbit"
At the 2023 Skin of Color Update, Dr. David Ciocon, Director of Dermatologic Surgery, Mohs Micrographic Surgery (MMS) and Procedural Dermatology at the Montefiore Medical Center, Albert Einstein College of Medicine, provided a comprehensive exploration of MMS in patients with skin of color, with a focus on defining keratinocyte carcinoma and shedding light on disparities within this patient popula … Continue reading "Mohs Micrographic Surgery in Skin of Color"
Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium interviewed Dr. Diane S. Berson, associate professor of dermatology at Weill Cornell Medical College. Watch as Dr. Berson shares the cosmeceutical ingredients that dermatology clinicians can use synergistically to address photodamage and hyperpigmentation. Learn what ingredients are newly available and how cosmeceutica … Continue reading "Cosmeceuticals for Photodamage and Hyperpigmentation"
